In clinical trial programs, certain subgroups of patients are excluded based on the respective inclusion criteria. Register studies provide additional data from everyday practice. To date, there have been few direct real-world comparisons of the efficacy of different biologics in patients with moderate to severe psoriasis. The international cohort study Psoriasis Study of Health Outcomes (PSoHO) was designed against this background. This is an ongoing study, with evaluations of partial samples currently available.
This content is machine-translated. Please contact us if you need professional translation services.
- DERMATOLOGIE PRAXIS